-- 
D-Pharm Climbs as FDA Puts Stroke Medication on ‘Fast Track’

-- B y   R o n i t   G o o d m a n
-- 
2011-04-14T14:04:48Z

-- http://www.bloomberg.com/news/2011-04-14/d-pharm-climbs-as-fda-puts-stroke-medication-on-fast-track-1-.html
D-Pharm Ltd. (DPRM)  rose the most in
almost two months after the biopharmaceutical company said its
DP-b99 drug for ischemic stroke was put on “fast-track” status
by the U.S. Food and Drug Administration.  The shares increased 4 percent, the biggest gain since Feb.
20, to 19.48 shekels at the 4:30 p.m. close in Tel Aviv, giving
the Rehovot, Israel-based company a market value of 284 million
shekels ($83 million)  To contact the reporter on this story:
Ronit Goodman in Tel Aviv at 
 rgoodman9@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  